1
|
Gacouin A, Guillot P, Delamaire F, Le Corre A, Quelven Q, Terzi N, Tadié JM, Maamar A. Impact of cardiovascular risk factors and cardiac diseases on mortality in patients with moderate to severe ARDS: A retrospective cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY. CARDIOVASCULAR RISK AND PREVENTION 2024; 22:200318. [PMID: 39234517 PMCID: PMC11372786 DOI: 10.1016/j.ijcrp.2024.200318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2024] [Revised: 07/02/2024] [Accepted: 08/08/2024] [Indexed: 09/06/2024]
Abstract
Background History of coronary artery disease (CAD) and/or atrial fibrillation (AF) and/or valvular replacement (VR) are prevalent among patients admitted to intensive care units (ICUs). The impact of these conditions on outcomes in patients with acute respiratory distress syndrome (ARDS) remains insufficiently explored. Methods We performed a retrospective study on prospectively collected data from patients with ARDS and a PaO2/FiO2 ratio ≤150 mmHg. Patients were admitted between January 2006 and March 2022. We used multivariable logistic regression analysis. The primary outcome was 1-year mortality from admission to the ICU; secondary outcomes included mortality at 28 days and 90 days. Results Among 1.033 patients, 181 (17.5 %) had a history of CAD and/or AF and/or VR. History of CAD and/or AF and/or VR was independently associated with 1-year mortality (Odds-Ratio (OR) = 2.59, 95 % confidence interval (CI) 1.76-3.82, p < 0.001), with mortality at 90 days (OR = 1.87, 95 % CI 1.27-2.76, p = 0.001), but not with mortality at 28 days (OR = 1.40, 95 % CI 0.93-2.11, p = 0.10). In sensitivity analyses, history of CAD and/or AF and/or VR remained independently associated with 1-year mortality in ICU survivors (OR = 3.58, 95 % CI = 2.41-7.82, p < 0.001). Conclusions History of CAD and/or AF and/or VR was associated with mortality in ARDS. Prompt referral to cardiologists for comprehensive management post-ICU discharge may be warranted to optimize outcomes in this vulnerable population.
Collapse
Affiliation(s)
- Arnaud Gacouin
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
- Inserm-CIC-1414, Faculté de Médecine, Université Rennes 1, IFR 140, F-35033 Rennes, France
| | - Pauline Guillot
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
| | - Flora Delamaire
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
| | - Alexia Le Corre
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
| | - Quentin Quelven
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
| | - Nicolas Terzi
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
- Inserm-CIC-1414, Faculté de Médecine, Université Rennes 1, IFR 140, F-35033 Rennes, France
| | - Jean Marc Tadié
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
- Inserm-CIC-1414, Faculté de Médecine, Université Rennes 1, IFR 140, F-35033 Rennes, France
| | - Adel Maamar
- CHU Rennes, Maladies Infectieuses et Réanimation Médicale, F-35033 Rennes, France
- Université Rennes 1, Faculté de Médecine, Biosit, F-35043 Rennes, France
| |
Collapse
|
2
|
Kanodia C, Bourne RS, Mansi ET, Lone NI. Association between critical care admission and chronic medication discontinuation post-hospital discharge: A retrospective cohort study. J Intensive Care Soc 2024; 25:255-265. [PMID: 39224430 PMCID: PMC11366179 DOI: 10.1177/17511437241230260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/04/2024] Open
Abstract
Background: Discontinuation of important chronic medication after hospitalisation is common. This study aimed to investigate the association between critical care (vs non-critical care) admission and discontinuation of chronic medications post-hospital discharge, along with factors associated with discontinuation among critical care survivors. Methods: This was a retrospective cohort study in Lothian, Scotland of adults who were admitted to hospital between 01/01/2012 and 31/12/2019 and survived to hospital discharge. Medication classes investigated were statins, angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEi/ARBs), beta-blockers, oral anticoagulants, and thyroid hormones. The risk of medication discontinuation for each class was estimated by odds ratios (OR), with 95% confidence intervals (95%CI), using multivariable logistic regression adjusted for patient demographics, main clinical condition, and index comorbidity. A secondary analysis assessed factors associated with discontinuation in critical care survivors. Results: There were 22,340 critical care and 367,185 non-critical care survivors included. Critical care admission had the highest association with ACEi/ARBs discontinuation (adjusted OR 2.41, 95%CI: 2.26-2.58), followed by oral anticoagulants (adjusted OR 1.33, 95%CI: 1.15-1.53), and beta blockers (adjusted OR 1.18, 95%CI: 1.07-1.29). There was no significant association with thyroid hormones or statin discontinuation. Among critical care survivors, hospital length of stay of 14 days or more was associated with increased discontinuation across all medication classes. Conclusion: Critical care admission was associated with discontinuation of three out of five medication classes studied (ACEi/ARBs, beta-blockers, and oral anticoagulants). Further research is needed to understand the reason for increased medication discontinuation in critical care survivors and how these risks can be mitigated to improve patient outcomes.
Collapse
Affiliation(s)
- Charvi Kanodia
- Edinburgh Medical School, University of Edinburgh, Edinburgh, UK
| | - Richard S Bourne
- Departments of Pharmacy and Critical Care, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, School of Health Sciences, The University of Manchester, Manchester, UK
| | | | - Nazir I Lone
- Edinburgh Medical School, University of Edinburgh, Edinburgh, UK
- Usher Institute, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
3
|
Bourne RS, Herridge MS, Burry LD. Less inappropriate medication: first steps in medication optimization to improve post-intensive care patient recovery. Intensive Care Med 2024; 50:982-985. [PMID: 38635046 DOI: 10.1007/s00134-024-07405-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 03/19/2024] [Indexed: 04/19/2024]
Affiliation(s)
- Richard S Bourne
- Departments of Pharmacy and Critical Care, Northern General Hospital, Herries Road, Sheffield, UK
- Faculty of Biology, Medicine and Health, Division of Pharmacy and Optometry, School of Health Sciences, The University of Manchester, Oxford Road, Manchester, UK
| | - Margaret S Herridge
- Respiratory and Critical Care Medicine, Temerty Department of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada
| | - Lisa D Burry
- Department of Pharmacy and Medicine, Leslie Dan Faculty of Pharmacy and Interdepartmental Division of Critical Care Medicine, Sinai Health, University of Toronto, Toronto, ON, Canada.
- Department of Pharmacy, Mount Sinai Hospital, Room 18-300E, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
| |
Collapse
|
4
|
Bourne RS, Jeffries M, Meakin E, Norville R, Ashcroft DM. Qualitative Insights Into Patients' and Family Members' Experiences of In-Hospital Medication Management After a Critical Care Episode. CHEST CRITICAL CARE 2024; 2:100072. [PMID: 38911128 PMCID: PMC11190841 DOI: 10.1016/j.chstcc.2024.100072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/25/2024]
Abstract
Background Patient recovery after a critical illness can be protracted, requiring a care continuum that extends along a patient pathway from the critical care unit, hospital ward, and into the community care setting. High-quality care on patient transfer from critical care, including medication safety, is facilitated by education for patients and families, family engagement, support systems, and health care professional (HCP)-patient communication. Currently, uncertainty exists regarding how HCPs can and should engage with critical care patients and family members about their medication. Research Question What are the views and experiences of critical care patients and family members about their involvement in, communication about, understanding of, and decision-making related to their medication after transfer from critical care to the hospital ward? Study Design and Methods This qualitative study used semistructured interviews, conducted with critical care patients and family members after transfer from critical care to a hospital ward in a large National Health Service hospital trust. Anonymized transcripts of interviews were analyzed thematically using a coding framework developed from understandings of patient and family engagement in medication administration. Results Twenty-seven participants (15 patients and 12 family members of patients) completed the interviews. We identified five themes and 15 subthemes, providing an overview of patients' and family members' views on medication management during acute illness and ongoing recovery. Themes identified were: impact of acute illness and treatment burden on preexisting illness, preexisting knowledge and capability, beliefs about persons roles and expectations, care continuity and individualized information exchange, and engagement in practice. Interpretation This study demonstrated that critical care patients and family members want to engage with HCPs about medication administration. HCPs must take an individualized approach to communication and timing, acknowledging the dynamic interplay between patients and family members, using multimodal forms of communication.
Collapse
Affiliation(s)
- Richard S. Bourne
- Critical Care Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England
- Department of Pharmacy, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
- National Institute for Health and Care Research Greater Manchester Patient Safety Research Collaboration, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
| | - Mark Jeffries
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
- National Institute for Health and Care Research Greater Manchester Patient Safety Research Collaboration, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
| | - Eleanor Meakin
- Critical Care Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England
| | | | - Darren M. Ashcroft
- Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
- National Institute for Health and Care Research Greater Manchester Patient Safety Research Collaboration, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, England
| |
Collapse
|
5
|
Casal GL, Bittner EA. Pump the Breaks on the Slide to Harm From Nonindicated Proton Pump Inhibitors After Critical Illness! Crit Care Med 2024; 52:334-337. [PMID: 38240512 DOI: 10.1097/ccm.0000000000006126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2024]
|